Breaking News

Merck to Build $650M Biomanufacturing Plant in NC

New 225,000 square foot facility to produce active ingredient for the Gardasil 9 vaccine

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Merck has unveiled plans to invest more than $650 million and create more than 400 jobs in North Carolina, building a new production facility at its Maurice R. Hilleman Center for Vaccine Manufacturing in Durham and expanding its packaging operations in Wilson. This substantial project will enable Merck to meet growing demand for Gardasil and Gardasil 9 recombinant human papillomavirus (HPV) vaccine, which is used to prevent several cancers associated with HPV.   “The life science industry clust...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters